CMT vs. AMRX
CMT (Core Molding Technologies, Inc.) and AMRX (Amneal Pharmaceuticals, Inc.) are both stocks. CMT operates in Specialty Chemicals (Basic Materials), while AMRX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, CMT returned 6.61%/yr vs -9.35%/yr for AMRX. At a 0.14 correlation, their price movements are largely independent.
Performance
CMT vs. AMRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CMT achieves a 17.26% return, which is significantly higher than AMRX's 2.18% return. Over the past 10 years, CMT has outperformed AMRX with an annualized return of 6.61%, while AMRX has yielded a comparatively lower -9.35% annualized return.
CMT
- 1D
- 0.81%
- 1M
- -8.38%
- YTD
- 17.26%
- 6M
- 22.45%
- 1Y
- 46.21%
- 3Y*
- 6.65%
- 5Y*
- 13.07%
- 10Y*
- 6.61%
AMRX
- 1D
- 1.78%
- 1M
- -1.79%
- YTD
- 2.18%
- 6M
- 5.71%
- 1Y
- 72.82%
- 3Y*
- 71.55%
- 5Y*
- 18.72%
- 10Y*
- -9.35%
CMT vs. AMRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CMT Core Molding Technologies, Inc. | 17.26% | 21.22% | -10.74% | 42.65% | 52.64% | -39.56% | 333.23% | -54.29% | -67.03% | 27.42% |
AMRX Amneal Pharmaceuticals, Inc. | 2.18% | 59.09% | 30.48% | 205.03% | -58.46% | 4.81% | -5.19% | -64.38% | -18.74% | 25.66% |
Correlation
The correlation between CMT and AMRX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 16, 2009 | 0.14 |
Fundamentals
CMT:
$1.48
AMRX:
$0.38
CMT:
15.89
AMRX:
34.22
CMT:
0.36
AMRX:
1.19
CMT:
0.56
AMRX:
1.37
CMT:
$270.93M
AMRX:
$3.05B
CMT:
$44.31M
AMRX:
$1.18B
CMT:
$18.05M
AMRX:
$626.02M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CMT vs. AMRX — Risk / Return Rank
CMT
AMRX
CMT vs. AMRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Core Molding Technologies, Inc. (CMT) and Amneal Pharmaceuticals, Inc. (AMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CMT | AMRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.37 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.33 | 3.29 | -0.96 |
| Martin ratioReturn relative to average drawdown | 4.69 | 8.19 | -3.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CMT | AMRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.13 | 2.32 | -1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.37 | -0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.11 | -0.14 | +0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.06 | 0.10 | -0.05 |
Drawdowns
CMT vs. AMRX - Drawdown Comparison
The maximum CMT drawdown since its inception was -96.21%, roughly equal to the maximum AMRX drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for CMT and AMRX.
Loading charts...
Drawdown Indicators
| CMT | AMRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.21% | -97.52% | +1.31% |
Max Drawdown (1Y)Largest decline over 1 year | -19.89% | -22.25% | +2.36% |
Max Drawdown (3Y)Largest decline over 3 years | -55.95% | -26.80% | -29.15% |
Max Drawdown (5Y)Largest decline over 5 years | -55.95% | -78.90% | +22.95% |
Max Drawdown (10Y)Largest decline over 10 years | -95.45% | -96.28% | +0.83% |
Current DrawdownCurrent decline from peak | -20.71% | -74.91% | +54.20% |
Average DrawdownAverage peak-to-trough decline | -53.35% | -54.31% | +0.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.89% | 8.92% | +0.97% |
Volatility
CMT vs. AMRX - Volatility Comparison
Core Molding Technologies, Inc. (CMT) has a higher volatility of 12.71% compared to Amneal Pharmaceuticals, Inc. (AMRX) at 9.50%. This indicates that CMT's price experiences larger fluctuations and is considered to be riskier than AMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CMT | AMRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.71% | 9.50% | +3.21% |
Volatility (6M)Calculated over the trailing 6-month period | 33.25% | 22.37% | +10.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.96% | 31.62% | +9.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.99% | 50.91% | -5.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.39% | 65.26% | -3.87% |
Dividends
CMT vs. AMRX - Dividend Comparison
Neither CMT nor AMRX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CMT Core Molding Technologies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.41% | 0.46% |
Financials
CMT vs. AMRX - Financials Comparison
This section allows you to compare key financial metrics between Core Molding Technologies, Inc. and Amneal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CMT vs. AMRX - Profitability Comparison
CMT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported a gross profit of 11.98M and revenue of 58.58M. Therefore, the gross margin over that period was 20.5%.
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 320.11M and revenue of 722.52M. Therefore, the gross margin over that period was 44.3%.
CMT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported an operating income of 764.00K and revenue of 58.58M, resulting in an operating margin of 1.3%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported an operating income of 133.54M and revenue of 722.52M, resulting in an operating margin of 18.5%.
CMT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported a net income of 605.00K and revenue of 58.58M, resulting in a net margin of 1.0%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a net income of 62.50M and revenue of 722.52M, resulting in a net margin of 8.7%.
Frequently Asked Questions
CMT and AMRX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CMT has higher volatility (12.71%) compared to AMRX (9.50%). In terms of maximum drawdown, CMT dropped -96.21% vs AMRX's -97.52%.
AMRX currently has the higher Sharpe Ratio (2.32 vs 1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CMT and AMRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer